Physician

Wasim Nasir, MD

According to 2025 Medicare claims, Wasim Nasir, MD (NPI: 1205222171) practices dermatology in the Flint, MI market, with the plurality of this provider's patient population coming from Genesee, MI. This provider's primary affiliated billing organization is DERMATOLOGY & COSMETIC CENTER PLLC (NPI: 1811605660; TIN: 920843065) and primary practice location at 48507-9998. Nasir is affiliated with the Advantage ACO (ACO ID: A5166), participating under the MSSP model.

Nasir's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 339 traditional Medicare patients, billed 6,316 HCPCS/CPT codes, and received $303,410 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 3,474 prescription claims across 839 beneficiaries totaling $2,407,020 in drug costs, led by Cosentyx Unoready Pen (Secukinumab). Open Payments data shows 293 records totaling $40,330. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider has fewer than 5 years of reported Medicare Part B carrier billing data, so a reliable trend cannot be assigned. Concurrently, Part D prescription costs have risen steadily, from $123 to $2,407,020. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$152K$303K2021 Medicare payment: $19,119 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $58,647 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $122,931 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $303,410 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
2020N/RN/RN/R
2021104358$19,119
20222111,020$58,647
20231902,291$122,931
20243396,316$303,410

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.2M$2.4M2015 Drug cost: $123 (USD; Tot_Drug_Cst)2016 Drug cost: $113 (USD; Tot_Drug_Cst)2018 Drug cost: $3,946 (USD; Tot_Drug_Cst)2019 Drug cost: $9,554 (USD; Tot_Drug_Cst)2020 Drug cost: $3,210 (USD; Tot_Drug_Cst)2021 Drug cost: $42,533 (USD; Tot_Drug_Cst)2022 Drug cost: $235,674 (USD; Tot_Drug_Cst)2023 Drug cost: $487,554 (USD; Tot_Drug_Cst)2024 Drug cost: $2,407,020 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20151111$123
2016N/R15$113
2017N/RN/RN/R
20182957$3,946
201964161$9,554
20201740$3,210
2021102237$42,533
2022205602$235,674
20234101,342$487,554
20248393,474$2,407,020

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99204New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more184184$107
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more212484$86
17110Destruction of skin growth, 1-14 growths150264$73
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more172302$66
17000Destruction of precancer skin growth, 1 growth123238$32

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Cosentyx Unoready PenSecukinumab581,614$678,805
Dupixent PenDupilumab1444,145$556,186
Skyrizi PenRisankizumab-Rzaa171,210$360,452
Humira(Cf) PenAdalimumab22616$226,590
Cosentyx Sensoready PenSecukinumab12336$87,549

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.293$40,330SUN PHARMACEUTICAL INDUSTRIES INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Wasim Nasir, MD?

Tedicare shows public-source Medicare data for Wasim Nasir, MD (NPI 1205222171), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Wasim Nasir, MD have ACO affiliation data?

Wasim Nasir, MD is shown with ACO affiliation data for Advantage ACO (MSSP, ACO ID A5166).

What billing organization is linked to Wasim Nasir, MD?

Wasim Nasir, MD is linked to DERMATOLOGY & COSMETIC CENTER PLLC (billing NPI 1811605660) in the available physician profile data.

Does Wasim Nasir, MD have Open Payments data?

Wasim Nasir, MD has 293 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.